Doravirine and the Potential for CYP3A-Mediated Drug-Drug Interactions

Identifying and understanding potential drug-drug interactions (DDIs) are vital for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. This article discusses DDIs between doravirine, a nonnucleoside reverse transcriptase inhibitor (NNRTI), and cytochrome P450 3A (CYP3A) substrat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Khalilieh, Sauzanne G., Yee, Ka Lai, Sanchez, Rosa I., Fan, Li, Anderson, Matt S., Sura, Monali, Laethem, Tine, Rasmussen, Scott, van Bortel, Luc, van Lancker, Griet, Iwamoto, Marian
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2019
Teme:
Antiviral Agents
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496093/
https://ncbi.nlm.nih.gov/pubmed/30783000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02016-18
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki